-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on Indivior, Raises Price Target to $41

Benzinga·10/31/2025 15:46:09
Listen to the news
Piper Sandler analyst David Amsellem reiterates Indivior (NASDAQ:INDV) with a Overweight and raises the price target from $27 to $41.